Month: September 2021

PRESS RELEASE Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 10 September 2021) Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announced that management will present at the following investor conferences in September.H.C. Wainwright 23rd Annual Global Investment ConferenceFireside Chat available on demand starting at 7:00 a.m. ET on Monday, September 13, 2021Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Fireside Chat: Wednesday, September 22, 2021 at 2:05 p.m. ETThe investor conferences will each be held...

      COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has engaged Hamilton Morris, the research scientist and film-maker, as a full-time consultant, who will be working primarily at the COMPASS Discovery Center, based at University of the Sciences in Philadelphia (USciences) in the United States. Mr Morris will be advising COMPASS on research related to new psychedelic compounds that could be developed into therapies in areas of unmet mental health need. Hamilton Morris is the creator and director of the documentary series Hamilton’s Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. He also carries out chemistry research at USciences, alongside the COMPASS...

CAMBRIDGE, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the grant of an inducement award outside of the Company’s 2019 Stock Incentive Plan to Mel Hayes, the Company’s newly appointed Chief Commercial Officer. The grant was approved by the Compensation Committee on August 4, 2021 as an inducement material to the employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement grant consisted of a nonstatutory option to purchase up to 140,000 shares of common stock. The option has an exercise price of $28.49 per share, the closing price per share of the Company’s common stock as reported by Nasdaq on...

Charlotte, N.C., Sept. 10, 2021 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that senior management will attend the 23rd Annual HC Wainwright Global Investment Conference on Tuesday, September 14, 2021. Meetings will take place virtually given the ongoing call for social distancing due to the Covid-19 pandemic. Investors that would like to schedule a meeting with Akoustis management should contact their HC Wainwright representative or Akoustis’ investor relations at ir@akoustis.com. Akoustis is actively delivering volume production of its WiFi 6 tandem filter solutions, shipping multiple 5G small cell XBAWTM filter solutions,...

TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) — GameSquare Esports Inc. (CSE: GSQ; FRA: 29Q1) (the “Company”), an international gaming and esports company, announces a change to the location of its annual and special meeting to be held on September 21, 2021, at 10:00 a.m. EST (the “Meeting”). The new location for the Meeting will be Suite 1008, 150 York Street, Toronto, ON. There is no change in the date or time of the Meeting. Due to the ongoing COVID-19 pandemic and to mitigate potential risks to public health and safety, access to the Meeting will be limited to essential personnel and others entitled to attend the Meeting, subject to capacity and other restrictions. The Company has organized a webcast of the Meeting whereby shareholders can listen to the Meeting live online at http://services.choruscall.ca/links/gamesquare20210921.html....

Event will focus on CVL-871, a D1/D5 partial agonist in development for dementia-related apathy, and will include an update on CVL-231, an M4 positive allosteric modulator for the treatment of schizophrenia Live webcast scheduled for Thursday, Oct. 7 from 10:00 to 11:30 a.m. ET CAMBRIDGE, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced it will host a virtual R&D event on Thursday, Oct. 7 from 10:00 to 11:30 a.m. ET. Hosted in a live webcast format, Cerevel will lead a discussion focused on CVL-871, a D1/D5 partial agonist for dementia-related apathy, as well as provide an update on CVL-231, its M4 positive allosteric modulator in development for the treatment of schizophrenia. This R&D event...

Because your child’s privacy matters The Children’s Online Privacy Protection Act (“COPPA”) and the General Data Protection Regulation (“GDPR”) compliance drive world-class privacy and consent policy features BLUE BELL, Pa., Sept. 10, 2021 (GLOBE NEWSWIRE) — REGO Payment Architectures, Inc. (“REGO”) (OTCQB:RPMT) today announced its MazoolaSM version 3.0 super app is now available for Android on Google Play. MazoolaSM offers families a digital wallet and comprehensive ecosystem to fully experience online and in-store commerce. And as the first and only independently certified COPPA compliant family mobile wallet, the super app continues to be “Powered by Privacy,” ensuring kids and teens partake in a safe and secure environment. REGO’s technology is protected by three patents: System and Method for Virtual Piggy Bank, System and...

Figure 1:Drilling Plan View, Pyramid Peak, Snoball PropertyTORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) — Evergold Corp. (“Evergold” or the “Company”) (TSX-V:EVER, FRA:A2PTHZ, OTC:EVGUF) is pleased to report that drilling is now underway on the Company’s high-grade gold-silver discovery on Pyramid Peak, located on its Snoball property in northwest BC’s Golden Triangle region. Two pads have now been constructed and a third is planned (Figure 1), all of which are located downslope to the southwest of drilling carried out in 2020 from the Apex pad. The program is targeting up to 2,000 metres of drilling, weather allowing. “It’s great to see the drill actually turning after the varied challenges getting to that point. Kudos to our exploration team under the guidance of Andy Mitchell and Charlie Greig, for getting us there,”...

Company Signs Agreement With Nationally Recognized Solar Engineer, KMB Design Group, To Lead Application Process – KMB Design Group Is A Full Service Engineering Solutions Provider That Has Provided Designs And Engineering Services For Over 1,000 Projects Nationwide With Over 1,500 MW Of Solar Designed NEW YORK, NY, Sept. 10, 2021 (GLOBE NEWSWIRE) — Green Stream Holdings Inc. (OTC PINK: GSFI) (“the Company”) (https://greensolarutility.com), an emerging leader in the solar utility and finance space, recently announced that it had engaged a nationally known a full service engineering solutions provider with extensive international expertise in the solar renewable energy field providing photovoltaic design and engineering services, to assist the Company in installing several ground-mount solar farms in the State...

– Management to host a call today at 8:00 am ET NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced its financial results for the second quarter ended June 30, 2021 and provided an update on recent corporate events. “We had a very productive first half of 2021. Importantly, we were thrilled to announce positive data from our registrational trial of plinabulin in 2nd/3rd line NSCLC, which showed significant improvement in overall survival, especially the doubling of 2-year and 3-year survival in the plinabulin and docetaxel arm vs. docetaxel alone. This underscores plinabulin’s immune durable anti-cancer benefit, which could be the gateway for its development...